News and Events
Recent News: Visit of Dr. Joel Vega-Rodriguez
URGENT: COVID BOOSTER ELIGIBILITY UPDATE: March 31, 2022
NOT-GM-22-032: Notice of Information Regarding NIGMS Changes to Candidate Eligibility for PA-21-071 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-22-032.html
Notice Number:
NOT-GM-22-032
Key Dates
Release Date:
March 29, 2022
Related Announcements
PA-21-071- Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
Issued by
National Institute of General Medical Sciences (NIGMS)
Purpose
The purpose of this Notice is to inform potential applicants of a change at NIGMS to the candidate level eligibility that will be considered for PA-21-071,“Research Supplements to Promote Diversity in Health-Related Research (Admin Supp — Clinical Trial Not Allowed).”
Effective immediately, NIGMS will begin accepting applications to support master’s degree students who are planning to apply to Ph.D. or M.D./Ph.D. programs. This change to the candidate level eligibility is part of the NIGMS Research Supplements to Promote Diversity in Health-Related Research, which facilitates the recruitment and training of promising scientists from diverse backgrounds (including individuals from underrepresented groups in the biomedical research workforce).
PD/PIs with eligible candidates are strongly encouraged to discuss potential diversity supplement requests with the below listed contacts along with the Program Officer of their grant before applying.
NIH Study reveals: Mandatory masking in schools reduced COVID-19 cases during Delta surge
Mandatory masking in schools reduced COVID-19 cases during Delta surge
What
Who
Reference
Recomendaciones sobre uso de mascarilla y protocolos vigentes para el control de exposición al COVID-19 en el RCM
A TODA LA COMUNIDAD UNIVERSITARIA
RECINTO DE CIENCIAS MÉDICAS
Recent Publication from the Department of Microbiology & Medical Zoology
Two NIAID Funding Opportunities: RFA on Susceptibility Testing, NOSI on Vascularized Composite Allografts
NIAID Funding Opportunities
|